The Ministry of Health and Prevention (MoHAP) in the UAE has withdrawn batch number ME051 of the API Sinocort Nasal Spray, a medication that's used to treat asthma and blocked airways.
The spray is manufactured by Amman Jordan Pharmaceutical Industries.
In a statement, MoHAP said the decision was made after a review of the batch showed it had failed to conform to the approved specifications.
Pharmacists and healthcare providers have been ordered to withdraw it from sale and return the drug to the suppliers
Users are advised to dispose of the batch and report any adverse reactions.
Dr. Amin Hussein Al Amiri, Assistant Undersecretary of the Ministry of Health and Prevention’s Public Health Policy and Licenses, and Chairman of the Supreme National Committee for Pharmacovigilance, urged people to contact them by email at ph@moh.gov.ae, through the E-system on MoHAP’s website, or the smart app ‘UAE RADAR.’
Jaywalking and scooter misuse claim 13 lives in Dubai
Watch: Abu Dhabi hosts test flight of pilotless air taxi
UAE carriers suspend, reroute flights after Israel strikes Iran
MBRGI completes major anti-malnutrition projects in Africa
UAE strongly condemns Israeli strikes on Iran
UAE President, Canada PM discuss bilateral ties during call
UAE President expresses solidarity with India following plane crash
UAE President, Pakistani Prime Minister pledge closer ties
